CJC-1295 No-DAC 5mg
$80.00
- Free US shipping over $150
- HPLC-tested at 99%+ purity
- US-based fulfillment
Overview
Description
A growth hormone–releasing peptide researched for supporting natural growth hormone signaling with a shorter-acting profile. Often chosen for recovery, sleep quality, and lean body composition support.
CJC-1295 (No-DAC) is commonly preferred when you want flexibility and a cleaner timing approach, without the longer duration associated with DAC-modified options.
Scientific Overview
CJC-1295 No-DAC is a synthetic growth hormone–releasing hormone (GHRH) analog designed without the Drug Affinity Complex (DAC). It has been studied for stimulating pulsatile growth hormone release from the pituitary and influencing downstream IGF-1 signaling in research settings. Compared with DAC-modified versions, No-DAC is associated with a shorter half-life and a more transient activity profile.
Product Details
- Compound: CJC-1295 No-DAC (synthetic GHRH analog)
- Vial Size: 5mg
- Purity: ≥99%
- Form: Lyophilized powder
This product is intended strictly for laboratory research purposes only. It is not approved for human or veterinary use by the FDA or any other regulatory agency. Store in a cool, dry environment prior to reconstitution and handle using appropriate laboratory and aseptic techniques.
Frequently asked questions
Yes. Every batch of CJC-1295 No-DAC 5mg undergoes independent third-party testing using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). The Certificate of Analysis is published and accessible from the product page.
CJC-1295 No-DAC 5mg sold by MHS Longevity is verified to 99%+ purity, with the result documented in each batch's Certificate of Analysis. Anything below that threshold is rejected before release.
The Certificate of Analysis for CJC-1295 No-DAC 5mg is available directly from the product page and on our Third-Party Test Results page. Each COA includes the batch identifier, test date, testing method, and verified purity percentage.
CJC-1295 No-DAC 5mg ships from our US-based facility with standard or expedited options. Orders over $150 qualify for free standard US shipping. All orders are packaged discreetly with documented handling protocols.
No. CJC-1295 No-DAC 5mg is supplied strictly for laboratory research purposes only. It is not approved by the FDA for human or veterinary use, and it is not intended to diagnose, treat, cure, or prevent any disease.
MHS Longevity is a veteran-owned operation focused on pharmaceutical-grade research compounds. We source from vetted manufacturers, batch-test independently with HPLC and Mass Spectrometry, and publish every Certificate of Analysis. Pricing is transparent and the testing process is documented end-to-end.
The DAC (Drug Affinity Complex) version carries an additional maleimidopropionyl group at a specific lysine residue that enables covalent binding to serum albumin, dramatically extending half-life in physiological systems. The No-DAC version lacks that modification and has a substantially shorter functional duration. The base 30-amino-acid sequence is the same in both forms.
Sermorelin is GHRH(1-29) — the native human GHRH amino-acid sequence. CJC-1295 No-DAC is Modified GRF(1-29) — the same length, but with four amino-acid substitutions to improve enzymatic stability. Both are GHRH-receptor agonists; CJC-1295 No-DAC has been engineered for longer in-vivo presence than unmodified Sermorelin.
CJC-1295 No-DAC is sent to an independent third-party laboratory for HPLC and Mass Spectrometry analysis before each batch is released. The lab's identifier and test date are published on the Certificate of Analysis for that batch, including explicit confirmation that the batch is the No-DAC form.
CJC-1295 No-DAC engages the GHRH receptor; Ipamorelin engages the ghrelin / growth-hormone-secretagogue receptor. These are two complementary entry points into the growth-hormone axis, and research protocols frequently study them together to characterize how the two pathways interact. We stock both as separately tested compounds, as well as a combined CJC-1295 No-DAC + Ipamorelin blend.
Research & buying
The evidence behind CJC-1295 No-DAC 5mg and the questions to ask any vendor before you order.
Research details — CJC-1295 No-DAC 5mg
CJC-1295 No-DAC is a synthetic 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH), often referred to in the literature as Modified GRF(1-29) or Mod GRF(1-29). It belongs to the GHRH family and is widely used in research alongside ghrelin-receptor agonists like Ipamorelin to study complementary pathways in the growth-hormone axis. This guide explains what CJC-1295 No-DAC is, how it differs from the DAC-modified version, and how each batch is verified.
What is CJC-1295 No-DAC?
CJC-1295 No-DAC has the sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2. It carries four amino-acid substitutions from native GHRH(1-29) that improve resistance to enzymatic degradation. The "No-DAC" designation distinguishes it from CJC-1295 with DAC, which carries an additional maleimidopropionyl group (the Drug Affinity Complex) that enables covalent serum-albumin binding and dramatically extends half-life. The No-DAC form has a shorter functional duration in research preparations because it lacks that albumin-binding moiety. It is supplied as a lyophilized white powder for laboratory reconstitution.
CJC-1295 No-DAC is sold strictly for laboratory and research use. It is not approved by the FDA or any other regulatory body for human or veterinary use, and nothing in this guide constitutes guidance for human administration.
Research context
Published research on Modified GRF(1-29) / CJC-1295 No-DAC focuses on the growth-hormone-releasing-hormone receptor pathway and its complementarity with the ghrelin / growth-hormone-secretagogue receptor pathway. Co-administration with ghrelin-receptor agonists (Ipamorelin, Hexarelin, GHRP-2/6) is a common research-protocol design, with publications examining synergistic versus additive effects on GH release in animal models. Researchers should evaluate primary sources directly.
How CJC-1295 No-DAC quality is verified
Every batch of MHS Longevity CJC-1295 No-DAC is submitted to an independent third-party laboratory before release:
- HPLC separates components by chemistry and measures the CJC-1295 No-DAC peak as a percentage of total peak area. Anything below 99% is rejected. Truncated synthesis products that elute close to the full-length peak are flagged in the chromatogram.
- Mass Spectrometry confirms the molecule's mass corresponds to the full 30-residue No-DAC sequence — and, importantly, that the maleimidopropionyl modification of the DAC variant is not present. This is how the two forms are distinguished analytically.
What a CJC-1295 No-DAC Certificate of Analysis shows
- Compound name and structural designation. CJC-1295 No-DAC / Modified GRF(1-29), with full sequence and molecular formula.
- Batch identifier. The unique ID linking certificate to vial.
- Test date. When the analysis was performed.
- Method. HPLC, MS, or both, with column and mobile-phase notes.
- Verified purity %. The HPLC result. We require 99%+.
- Form confirmation. Mass-spectrometry confirmation that the molecule is the No-DAC form, not the DAC-modified form.
- Lab and signatures. The independent lab performing the analysis.
Storage and handling (research lab context)
Lyophilized CJC-1295 No-DAC should be stored at -20°C or below for extended stability. Once reconstituted in bacteriostatic water, the solution is typically held at 2–8°C. Repeated freeze–thaw cycles should be avoided, and the powder should be protected from light and moisture. Standard aseptic technique applies during reconstitution.
Where to buy CJC-1295 No-DAC 5mg
The same eight questions apply whether you're buying CJC-1295 No-DAC 5mgfrom us or anywhere else. Vendors who can't answer any of them are worth a closer look.
Vendor evaluation checklist
1. Is the Certificate of Analysis public and downloadable?
A vendor unwilling to publish HPLC/MS results for the batch you're buying has nothing to verify their purity claim against.
2. Which testing method was used — HPLC, Mass Spectrometry, or both?
HPLC measures purity. Mass Spectrometry confirms the molecule's identity. Reputable batches go through both.
3. What's the verified purity percentage on the published COA?
Industry research standard is 99%+. Below that, you're paying for a compound diluted with synthesis byproducts.
4. Where does the product ship from?
US-based fulfillment generally means shorter handling times, customs-free delivery, and clearer return remedies.
5. Is the price published at a single list rate, or hidden behind tier locks?
Opaque pricing is a yellow flag. Transparent vendors quote the same number to every customer.
6. What's the free-shipping threshold, if any?
Compare the all-in cost (product + shipping + handling) — not just the headline price.
7. How is the product stored prior to shipment?
Lyophilized peptides degrade with temperature swings. Vendors should disclose temperature-controlled storage.
8. Is there a documented damage-claim and return policy?
Discreet shipping carries handling risk. A clear, written policy protects you when something goes wrong.
MHS LongevityThis site - Price
- $80
- Purity
- 99%+
- Testing
- HPLC + MS
- COA public
- US-based
- Free shipping
- $150+
- Last checked
- May 13, 2026
| Vendor | Price | Listed purity | Testing method | COA public | US-based | Free shipping | Last checked |
|---|---|---|---|---|---|---|---|
MHS LongevityThis site | $80 | 99%+ | HPLC + MS | $150+ | May 13, 2026 |
Competitor data sourced from each vendor's public product page on the date shown. Listed purity reflects each vendor's own published claim; Certificate of Analysis availability is verified at the URL above. Data may have changed since last check.